BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 32473632)

  • 1. Functional oral nanoparticles for delivering silibinin and cryptotanshinone against breast cancer lung metastasis.
    Liu Y; Xie X; Hou X; Shen J; Shi J; Chen H; He Y; Wang Z; Feng N
    J Nanobiotechnology; 2020 May; 18(1):83. PubMed ID: 32473632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal transfer of wheat germ agglutinin modified lipid-polymer hybrid nanoparticles for oral delivery of oridonin.
    Liu Y; Liu J; Liang J; Zhang M; Li Z; Wang Z; Dang B; Feng N
    Nanomedicine; 2017 Oct; 13(7):2219-2229. PubMed ID: 28539275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic inhibition of breast cancer metastasis by silibinin-loaded lipid nanoparticles containing TPGS.
    Xu P; Yin Q; Shen J; Chen L; Yu H; Zhang Z; Li Y
    Int J Pharm; 2013 Sep; 454(1):21-30. PubMed ID: 23830941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
    Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y
    J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of Platycodonis Radix-Curcumae Rhizoma on oral nanoparticle uptake and in vitro inhibition against breast cancer metastasis].
    Shi JP; Zhang RG; Gu XY; Sun YW; Feng NP; Liu Y
    Zhongguo Zhong Yao Za Zhi; 2023 May; 48(9):2419-2425. PubMed ID: 37282871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and evaluation of schisandrin B-loaded F127 modified lipid-polymer nanoparticles for inhibition of breast cancer lung metastasis].
    Fei Y; Jiang-Pei S; Hai-Zhen C; Jun-Yi S; Xing-Mei X; Zi-Fei J; Xiao-Yan GU; Ying L; Nian-Ping F
    Zhongguo Zhong Yao Za Zhi; 2020 Nov; 45(21):5177-5183. PubMed ID: 33350233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD.
    Liang J; Liu Y; Liu J; Li Z; Fan Q; Jiang Z; Yan F; Wang Z; Huang P; Feng N
    J Nanobiotechnology; 2018 Sep; 16(1):64. PubMed ID: 30176941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles.
    Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y
    Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of shell composition in shell-core structured nanoparticles on oral physiological barrier and bioavailability].
    Chen HZ; Shi JP; Gu XY; Peng YZ; Gao YZ; Liu Y; Feng NP
    Zhongguo Zhong Yao Za Zhi; 2022 Jul; 47(13):3475-3480. PubMed ID: 35850798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models.
    Guo C; Chen Y; Gao W; Chang A; Ye Y; Shen W; Luo Y; Yang S; Sun P; Xiang R; Li N
    Theranostics; 2017; 7(3):775-788. PubMed ID: 28255366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage-cancer hybrid membrane-coated nanoparticles for targeting lung metastasis in breast cancer therapy.
    Gong C; Yu X; You B; Wu Y; Wang R; Han L; Wang Y; Gao S; Yuan Y
    J Nanobiotechnology; 2020 Jun; 18(1):92. PubMed ID: 32546174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-targeted delivery of silibinin and IPI-549 synergistically inhibit breast cancer by remodeling the microenvironment.
    Jiang M; He K; Qiu T; Sun J; Liu Q; Zhang X; Zheng H
    Int J Pharm; 2020 May; 581():119239. PubMed ID: 32194211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional lipid polymeric nanoparticles for oral drug delivery: Rapid mucus penetration and improved cell entry and cellular transport.
    Liu Y; Jiang Z; Hou X; Xie X; Shi J; Shen J; He Y; Wang Z; Feng N
    Nanomedicine; 2019 Oct; 21():102075. PubMed ID: 31377378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RGD peptide-modified, paclitaxel prodrug-based, dual-drugs loaded, and redox-sensitive lipid-polymer nanoparticles for the enhanced lung cancer therapy.
    Wang G; Wang Z; Li C; Duan G; Wang K; Li Q; Tao T
    Biomed Pharmacother; 2018 Oct; 106():275-284. PubMed ID: 29966971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Shrapnel nanoparticles loading docetaxel inhibit metastasis and growth of breast cancer.
    Xu P; Meng Q; Sun H; Yin Q; Yu H; Zhang Z; Cao M; Zhang Y; Li Y
    Biomaterials; 2015 Sep; 64():10-20. PubMed ID: 26106797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multifunctional ROS-Responsive and TME-Modulated Lipid-Polymer Hybrid Nanoparticles for Enhanced Tumor Penetration.
    Ni R; Huang L; Li Z; Zhang W; Wang Y; Shen Y; Wang J; Lu W
    Int J Nanomedicine; 2022; 17():5883-5897. PubMed ID: 36478745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-trimethyl chitosan nanoparticles and CSKSSDYQC peptide: N-trimethyl chitosan conjugates enhance the oral bioavailability of gemcitabine to treat breast cancer.
    Chen G; Svirskis D; Lu W; Ying M; Huang Y; Wen J
    J Control Release; 2018 May; 277():142-153. PubMed ID: 29548985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid curcumin-phospholipid complex-near-infrared dye oral drug delivery system to inhibit lung metastasis of breast cancer.
    Liu Y; Huang P; Hou X; Yan F; Jiang Z; Shi J; Xie X; Shen J; Fan Q; Wang Z; Feng N
    Int J Nanomedicine; 2019; 14():3311-3330. PubMed ID: 31190795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.